Status:
COMPLETED
Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages
Lead Sponsor:
Stanford University
Conditions:
Acute Mountain Sickness
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
Brief Summary
This double blind randomized trial will compare acetazolamide taken the morning of ascent to acetazolamide taken the evening prior to ascent for the prevention of acute mountain sickness (AMS). The da...
Detailed Description
The specific aim of this study is to determine whether acetazolamide started the day-of ascent is inferior to the standard night before ascent dose of acetazolamide for the prevention of acute mountai...
Eligibility Criteria
Inclusion
- Age 18-75 healthy non-pregnant volunteer
- live at low elevation \< 4000 ft
- Arrange your own transportation to WMRS (Bishop) by Friday evening of study weekend
- Available for full study duration (Friday PM-Sunday AM)
Exclusion
- Age \<18 or \>75, Pregnant, Live at altitude \>4000 ft Slept at altitude \> 4000ft within 1 week of study Allergic to acetazolamide, sulfa drugs, Taking non-steroidal anti-inflammatory drugs, Acetazolamide, or Corticosteroids 1 week prior to study
Key Trial Info
Start Date :
August 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2018
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03424226
Start Date
August 4 2018
End Date
September 30 2018
Last Update
November 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305